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Ergot alkaloids produced by a fungal endophyte (Epichloë coenophiala; formerly
Neotyphodium coenophialum) that infects tall fescue (Lolium arundinaceum) can induce
persistent constriction of the vasculature in ruminants, hindering their capability to thermo-regulate core body temperature. There is evidence that isoflavones produced by legumes
can relax the vasculature, which suggests that they could relieve ergot alkaloid-induced
vasoconstriction and mitigate the vulnerability to severe heat stress in ruminants that graze
tall fescue. To test if isoflavones can relieve alkaloid-induced vasoconstriction, two pen
experiments were conducted with rumen-fistulated goats (Capra hircus) to determine with
ultrasonograpy if isoflavones can (1) promote vascular compliance by countering alkaloid-
induced vasoconstriction and (2) relieve already imposed alkaloid-induced vasoconstriction.
Goats were fed ad libitum chopped orchardgrass (Dactylis glomerata)–timothy (Phleum
pratense) hay prior to conducting the experiments. Measures of carotid and interosseous
luminal areas were obtained pre- (baseline) and post-ruminal infusions in both experiments
with goats being fed the hay, and for blood flow rate in the carotid artery in Experiment 2.
Responses to infusion treatments were evaluated as proportionate differences from baseline measures. Peak systolic velocity, pulsatility index, and heart rate were measured on the
last day on treatment (DOT) in Experiment 1, and on all imaging sessions during Experiment
2. For Experiment 1, rumens were infused with ground toxic fescue seed and isoflavones
in Phase A and with only the toxic seed in Phase B. The infusion treatments were switched
between phases in Experiment 2, which employed a fescue seed extract having an ergot
alkaloid composition equivalent to that of the ground seed used in Experiment 1. During
Experiment 1, luminal areas of carotid and interosseous arteries in Phase A did not deviate
(P > 0.1) from baselines over 1, 2, 3, and 4 DOT, but the areas of both declined linearly from
baselines over 1, 2, 3, and 4 DOT in Phase B. By 6, 7, and 8 DOT in Experiment 2, luminal
areas of the arteries and flow rate declined from baselines with infusions with the only seed
extract in Phase A, but luminal areas and flow rate increased over 4, 5, and 6 DOT with the
additional infusion of isoflavones. Peak systolic velocity and heart rate were not affected by
treatment in either experiment, but were highest when infused with only ergot alkaloids in
both experiments. Treatment with isoflavones was demonstrated to relax the carotid and
interosseous arteries and reduce resistance to blood flow. Results indicate that isoflavones
can relax persistent vasoconstriction in goats caused by consumption of ergot alkaloids,
and mitigate the adverse effect that ergot alkaloids have on dry matter intake.
Keywords: ergot alkaloids, goats, isoflavones, tall fescue, vasoconstriction
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INTRODUCTION

periodically to make sure that body weights of the mature goats
were stable during the experiment. Handling of goats and data
collection followed procedures approved by the University of
Kentucky Institutional Animal Care and Use Committee (protocol number 2013-1152).
With the low number of fistulated goats available for the study
and the possibility of amelioration of ergot alkaloid-induced vasoconstriction being subtle and over a long period of time, it was
decided to keep all goats on the same infusion treatment within
a phase for each experiment. Carry-over effects of ergot alkaloids
are not understood, so the goats were kept on the non-toxic hay
for 78 days between the two experiments. Furthermore, conduct
of the experiments in a controlled environment (21 ± 1°C) minimized confounding effects of time and changes in environmental
conditions.

Tall fescue (Lolium arundinaceum) is a cool-season perennial
grass that covers ~15 million hectares in the eastern half of the
USA and is extensively utilized for livestock grazing. The grass
is productive and tolerant of environmental stresses, which has
been attributed to the presence of a fungal endophyte (Epichloë
coenophiala) that infects most plants of tall fescue (1). However,
ergot alkaloid toxins are also produced by the endophyte, and
they cause a toxicosis in grazing livestock. Signs of “fescue toxicosis” include poor weight gain and reproductive performances,
elevated body temperature, labored respiration, and decreased
serum prolactin (2, 3).
Ergot alkaloids bind biogenic amine receptors in the vasculature (4) to induce persistent vasoconstriction (5) that incapacitates
the animal’s ability to regulate core body temperature (6, 7). Cattle
(5, 8), sheep (9), horses (10), and goats (11) have been reported
to vasoconstrict when exposed to ergot alkaloids. Therefore, the
vasculatures of these livestock species are vulnerable to ergot
alkaloid-induced vasoconstriction. Ergot alkaloids also bind D2
receptors of the anterior pituitary gland to reduce secretion of
prolactin (3, 4).
Isoflavones are phytoestrogens commonly found in legumes
and can have estrogenic activity in mammals (12). Isoflavones
have been used as a treatment for ameliorating hot flashes in
postmenopausal women (13, 14). Cruz et al. (15) used in vitro
techniques with small arteries collected from subcutaneous
circulation of men with and without coronary heart disease to
determine a vaso-relaxation response with exposure to phytoestrogens, resveratrol and genistein. Relaxation of the vasculature
from exposure to isoflavones has been associated with agonist
activity of isoflavones at β-adrenergic receptors in the vasculature
endothelium to stimulate synthesis of nitric oxide that mediates
vaso-relaxation (13–16). Recently, Shappell et al. (17) reported
an additive effect of combining estradiol implants with feeding
soybean hulls on the estrogenic activity of serum from steers
grazing toxic tall fescue. Although it could not be concluded, the
mitigation of fescue toxicosis observed with this treatment combination (18) could have been related to estrogenic activity with
the treatment combinations being above a threshold for relief of
vasoconstriction to occur. It could be possible that β-agonist activity of isoflavones could ameliorate the persistent vasoconstriction
caused by ergot alkaloids. Therefore, a pen study was conducted
using color Doppler and B-mode ultrasonography to determine
if treatment of wether goats with isoflavones can mediate relaxation of their carotid and interosseous arteries during and after the
occurrence of ergot alkaloid-induced vasoconstriction.

Isoflavone Analysis

Promensil® (Natrol Inc., Chatsworth, CA, USA), an over-thecounter red clover dietary supplement that has been safely
administered to humans in clinical studies (19) was infused
trans-ruminally as a source of isoflavones.
For assaying isoflavones in the red clover tablets (~600 mg),
tablets were incubated in 7.5 mL water in a 50-mL tube for about
30 min (including 10 min at 27–32°C) to dissolve other additives
in the tablets. After a brief centrifugation (3 min, 25°C, 2200 × g),
the supernatant was discarded. Loss of isoflavones in this first step
was expected to be minimal because preliminary extractions in
water had demonstrated that after 1–2 h of stirring or sonicating,
~2.3 mg of isoflavones (6% of the expected total) was recovered.
The pellet recovered from the above centrifugation was then
extracted after the method of Flythe and Kagan (20), but with
volumes modified for the larger samples, and with some heating to approximate changes that might occur in the rumen. The
pellet remaining after the water incubation was sonicated for
30 min, 28–35°C, in 8.4 mL 85% MeOH in 0.5% aqueous acetic
acid. This extraction solvent included an internal standard,
consisting of 0.58 mM catechin (Sigma-Aldrich, St. Louis, MO,
USA) prepared in MeOH. After addition of 3.6 mL water (final
solvent composition of 60% MeOH in 0.35% aqueous acetic
acid), samples were centrifuged (8 min, 25°C, 2200 × g,), and
5 mL supernatant was filtered through a 0.45-μm hydrophilic
membrane (GH Polypropylene, Pall Life Sciences, Ann Arbor,
MI, USA). A portion of filtrate was diluted threefold in the same
methanol–acetic acid solvent (to be within the range of the
standard curve) and used for high-performance liquid chromatography (HPLC) analysis. Diluted extracts were separated on an
Agilent 1100 HPLC system equipped with a Merck LiChrospher
RP-18 endcapped column (250 mm length × 4.6 mm i.d.), using
separation conditions described previously (21). Isoflavones
were monitored at 270 nm and quantified based on calibration
curves of standards purchased from Sigma-Aldrich (biochanin
A) or Indofine Chemical (genistein). Aglycones and their corresponding glycosides, if identifiable, were summed to give the
total amounts of each isoflavone of interest. Formononetin was
quantified based on a biochanin A calibration curve, which
decreased the final formononetin concentrations by about 20%

MATERIALS AND METHODS
Two independent experiments were conducted in the basement
of the Garrigus Building on the University of Kentucky Campus
using in-door pens maintained at ambient temperature of ~21°C.
The same set of six Spanish, wether goats that were ~2-year old
and with rumen fistulas were used in both experiments. Initial
body weights for Experiments 1 and 2 averaged 36.3 ± 2.6 (SD)
and 38.6 ± 5.0 kg, respectively. Goats were weighed initially and
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and, thus, gave a slightly more conservative number. Genistein
was quantified with a genistein calibration curve. Genistin, the
genistein glucoside, was not included in the genistein quantification because it was not detectable at the concentrations injected.
Similarly, daidzein was not detected.
The amounts of biochanin A, formononetin, and genistein
(representing the sum of aglycones and corresponding glycosides
if present) were corrected for recovery, based on the amount of
catechin recovered in extracts. Recoveries were about 80%. When
biochanin A, formononetin, and genistein content were averaged
among six replicates, the mean concentrations per tablet, with
the extraction and analytical methods used, were 5.7 ± 0.7 mg
biochanin A, 5.2 ± 1.0 mg formononetin, and 0.42 ± 0.05 mg
genistein. These results did not include the contribution from
the biochanin A malonylglucoside, and they underestimated the
amount of formononetin by about 20% because formononetin
was quantified with a biochanin A calibration curve, which has a
higher response factor.

to decrease ammonia production in mixed goat rumen bacteria
in vitro (24), the amount of the Promensil extract needed for each
goat was based on the amount needed to achieve a biochanin A
concentration of 30 mg per liter of rumen. The volume of the goat
rumen was estimated at 8.5 L.

Experiment 1

The goats were fed chopped orchardgrass–timothy hay ad libitum
for 35 days prior to start of infusion treatments. During Phase
A of the experiment, goats were infused daily with endophyteinfected seed and isoflavones in amounts that were previously
discussed. Phase B was conducted with infusion of only the toxic
ground seed for a 5-day duration.
Color Doppler ultrasound images of the cross-sections of
the left common carotid artery and left recurrent interosseous
artery over the scapula-humerus joint were collected using a
Classic Medical TeraVet 3000 Ultrasound Unit (Classic Universal
Ultrasound, Tequesta, FL, USA) with a 12L5-VET (12 MHz)
linear array transducer. Hair was kept clipped with surgical clippers at each site to maintain consistent transducer placement at
each imaging session. Baseline measures for hay feeding with no
rumen infusions were collected for each goat on the day before
and the fourth and fifth days prior to start of infusions for the
Phase A. Images were collected on days 1, 2, 3, and 4, and during
Phase B on days 1, 2, 3, 4, and 5. Each imaging session was started
at ~1100 hours and was done in 30–40 min. Five images were
collected and stored for each artery using a pulse frequency of
5.0 MHz. Scan depth was set at 4 cm for the common carotid
artery and 3 cm for the recurrent interosseous and caudal arteries.
Following freezing of an individual scan, frames stored in the cine
memory of the unit were searched to store the image exhibiting
the maximum flow signal and assumed to be at peak systolic
phase. The flow signal was traced to estimate lumen area (8).
On the final day on treatment (DOT) for each infusion
treatment, five longitudinal images of the left common carotid
arteries also were collected using Pulse Wave Doppler feature to
measure peak systolic velocity, heart rate, and pulsatility index.
Pulsatility index was used as an indicator of vascular resistance
(25). Images were collected on the last DOT that cross-sectional
images were collected for the two infusion treatments, but not
for baseline measures. Doppler spectra were collected using a
Doppler frequency of 5.0 MHz, a correction angle of 60°, and a
sample volume size of 1.0 mm.

Infusion Treatments

Rumen infusion treatments were evaluated in each experiment.
Goats were penned as pairs and were adapted to ad libitum
consumption of a chopped orchardgrass (Dactylis glomerata)–
timothy (Phleum pratense) hay for a minimum of 35 days prior
to initiation of the infusion treatments. Quantity of Promensil
infused daily (~27 g) was set to provide 30 mg/L of biochanin
A, the isoflavone of highest concentration in the red clover
tablets. In Experiment 1, ground toxic endophyte-infected
seed of “Kentucky 31” tall fescue and isoflavones were infused
in combination into the rumen of each goat during the Phase
A of the experiment. Seed was ground using a Wiley Mill with
5.0 mm screen. Quantities of ground seed infused daily were
targeted to provide a diet concentration of ~0.8 μg/g of diet DM
of ergovaline plus its epimer, ergovalinine. Amounts of seed were
daily adjusted based on the previous day’s consumption for each
goat pair. In Experiment 2, toxic seed was replaced with an extract
of toxic endophyte-infected tall fescue that was generated following procedures described by Foote et al. (22). The extract was
wrapped in a soft tortilla for infusion in a quantity that targeted a
diet concentration of 1.1 μg ergovaline/ergovalinine per g DM of
hay. Ground seed used in Experiment 1 and seed extract used in
Experiment 2 were from composite of seed samples from bags of
the endophyte-infected cultivar, “Defiance.” Seed and extract were
analyzed for concentrations of the ergopeptine, ergovaline, and its
epimer, ergovalinine, using procedures of Yates and Powell (23)
and modified as described by Carter et al. (18). Concentrations
of ergovaline/ergovalinine in the seed averaged 2.33 μg/g, and the
amount in daily fed seed extract per goat was 722.0 μg.
Chopped orchardgrass–timothy hay was fed ad libitum. Seed
that was previously coarse-ground using a Wiley Mill with a 5.0mm screen was infused into each rumen using a funnel. Feeding
of hay and rumen infusions were done at 1500 hours each day.
During the experimental periods, the previous day’s intake for
each pen was used to estimate intake per goat and the ratio of fed
chopped hay to rumenally infused seed for providing a daily diet
concentration of 0.8 μg of ergovaline and ergovalinine, per gram
of dry matter. Because a 30 ppm dose of biochanin A was found
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Experiment 2

The goats were fed chopped orchardgrass–timothy hay ad libitum
for 77 days prior to start of infusion treatments. The seed extract
was rumenally infused daily into each goat for 8 days during
Phase A, and both the seed extract and isoflavones were infused
for 6 days during Phase B.
Ultrasound B-mode images of the cross-sections of the left
common carotid and left recurrent interosseous arteries were collected with a Z. One Ultra SP System (Zonare Medical Systems,
Inc., Mountain View, CA, USA) using the L14-5W linear array
transducer. Baseline measures for hay feeding with no rumen
infusions were collected for each goat on the same days prior to
initiation of the infusion treatment as for Experiment 1. Another
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difference from Experiment 1 was that images were collected on
latter days during each phase when, based on observations in
Experiment 1, a response was assumed to be present. Images were
collected during Phase A on days 6, 7, and 8, and during Phase
B on days 4, 5, and 6. The B-mode images were collected using
a frequency of 5.0 MHz. Five image clips were stored for each
artery for freezing the still image exhibiting the maximum flow
signal and assumed to be at peak systolic phase for measurement
of lumen diameter and calculation of luminal area. The elastin
tissue in the endothelial intima was used for tracing the lumen
and estimating luminal area (8).
Similar to Experiment 1, five longitudinal images of the left
common carotid arteries also were collected using the Pulse Wave
Doppler feature to measure peak systolic velocity, mean velocity,
heart rate, and pulsatility index; however, unlike Experiment 1,
the images were collected when baseline cross-sectional images
were collected, and after initiation of infusion treatments on DOT
when cross-sectional images were collected. Instrument settings
were the same between both experiments.

and subtracted from measures made during the two phases of
each experiment, and divided by the average baseline measure
to estimate the proportionate difference. Infusion treatment was
analyzed as a discrete variable and DOT was evaluated as a continuous variable. In the presence of interaction between infusion
treatment and DOT, least square means for luminal areas in both
experiments and blood flow rate in the carotid artery measured
in Experiment 2 were evaluated as being above, below, or similar
(P < 0.05) to baseline measures. Linear trends over DOT for each
infusion treatment were determined as described by Littell et al.
(26) using mixed models.
Blood flow characteristics for the carotid were analyzed using
the same statistical model as the artery luminal areas, with the
exception that actual measures and not proportionate differences
were analyzed. The PDIFF option was used for comparisons of
least square means between baselines and the two infusion treatments in Experiment 2.

RESULTS
Experiment 1

Statistical Analyses

Baseline measures of the carotid luminal areas averaged
12.1 ± 0.7 mm2. There were no trends over DOT during Phase
A with infusions of toxic seed and isoflavones. However, carotid
luminal areas were similar (P > 0.12) to baselines for the first
2 days, but were greater (P < 0.05) than baselines on days 3 and 4
(Figure 1). During infusion with only the toxic seed in Phase B,
there was a linear decline in carotid luminal area over DOT. Mean
luminal area fell below the baseline by day 3 (26% decrease from
the baseline measure) and remained proportionately less on day
4 (45% decrease from the baseline measure).

Proportionate differences of luminal areas of arteries during the
phases from baseline measures were analyzed using mixed models
of SAS as repeated measures with the autoregressive covariance
(26). The analysis used individual animals as the experimental
unit. Infusion treatment, DOT, and the interaction between
infusion treatment and DOT were analyzed as fixed effects for
both experiments, and goat and goat × fusion treatment were
evaluated as random effects. Measures from images collected
when hay was fed with no infusions were averaged for each goat

FIGURE 1 | Ultrasonic measures in Experiment 1 of proportionate differences from baseline measures for luminal area of the carotid artery in rumenfistulated wether goats that were infused with (A) toxic endophyte-infected tall fescue seed and isoflavones in phase A, and (B) toxic seed only in
phase B. Baseline measures were taken with goats receiving ad libitum chopped orchardgrass (Dactylis glomerata)–timothy (Phleum pratense) hay with no rumen
infusions. Images for determining baseline measures were collected when goats were being adapted to the hay diet on the last, fourth, and fifth days prior to
initiating the infusion treatments. Asterisks above the bars denote significant differences between treatment and baseline measures at P < 0.05 (*), P < 0.01 (**), and
P < 0.001 (***) levels of significance. A trend line is provided for Phase B that illustrates the linear relationship between proportionate differences from baseline and
days on treatment.
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over 4, 5, and 6 days after isoflavones were included in the infusion treatment and were similar to baseline by 6 DOT.
Mean luminal area of the interosseous artery also was stable
and less than baseline measures (0.7 ± 0.1 mm2) over 6, 7, and 8
DOT when only the seed extract was infused (Figure 5). Decreases
in interosseous luminal areas ranged from 34.2 to 41.3% of the

Interosseous luminal areas (mean baseline measure = 2.7 ± 0.1 mm2) with infusions of toxic seed and isoflavones
during Phase A did not differ from baseline measures, but were
increasingly less than the baseline over DOT during Phase B
when only the toxic seed was infused (Figure 2). Mean luminal
areas were proportionately less than baselines on 2, 3, and 4 DOT
during Phase B, with ranges in areas relative to the baseline of
22% at 2 DOT to 45% at 4 DOT.
There were no differences between the infusion treatments
(Table 1) on peak systolic velocity (P = 0.47) or heart rate
(P = 0.712). A greater pulsatility index occurred at the conclusion of Phase B, during which only toxic seed was infused, which
indicated greater resistance to blood flow with infusion of ergot
alkaloids and less resistance to blood flow when isoflavones were
combined with the toxic seed in the infusion.

TABLE 1 | Mean responses (±SEM) of blood flow characteristics in
rumen-fistulated wether goats in Experiment 1 when toxic tall fescue
seed and isoflavones were rumenally infused in Phase A and only toxic
tall fescue seed was infused in Phase B, and in Experiment 2 when toxic
seed extract only was infused in Phase A and toxic seed extract and
isoflavones were infused in Phase B.
Experiment
1

Experiment 2

After being infused with the seed extract for 6 days in Phase A,
mean carotid luminal areas were proportionately less than baseline measures (14.5 ± 1.0 mm2) to the same extent over 6, 7, and
8 DOT (Figure 3), averaging ~41% decrease in area relative to
the baseline. Carotid luminal area was still less than the baseline
on day 4 after including the isoflavones with the seed extract;
however, the areas increased linearly over DOT and were similar
to baselines on 5 and 6 DOT.
Blood flow rate in the carotid artery responded similarly as
luminal area of the artery (Figure 4). Flow rates were proportionately less than the baseline measures after fescue seed extract
infusion (112 ± 10 mL/min.) over 6, 7, and 8 DOT, and the areas
averaged ~47% of baseline areas. Flow rates increased linearly

Measure

Baseline

Peak systolic
velocity, cm/s
Pulsatility
index

Peak systolic
velocity, cm/s
Pulsatility
index
Heart rate,
bpm

Phase B

29.8 ± 3.6

33.2 ± 2.6

1.41 ± 0.18b

3.39 ± 0.71a

61 ± 4

63 ± 3

23.4 ± 1.7

24.1 ± 2.3

20.4 ± 2.0

1.24 ± 0.11b

1.63 ± 0.13a

1.42 ± 0.13a,b

Heart rate,
bpm
2

Phase A

60 ± 3

52 ± 3

56 ± 3

The infusion treatments were reversed between the two phases in Experiment 2. Goats
were fed ad libitum chopped orchardgrass–timothy grass hay and baseline measures
for Experiment 2 were obtained during the adaptation period when the goats were fed
the hay prior to initiating the infusion treatments.
a,b
Measures within rows with different superscripts are different (P ≤ 0.05).

FIGURE 2 | Ultrasonic measures in Experiment 1 of proportionate differences from baseline measures for luminal area of the interosseous artery in
rumen-fistulated wether goats that were infused with (A) toxic endophyte-infected tall fescue seed and isoflavones in phase A, and (B) toxic seed
only in phase B. Baseline measures were taken with goats receiving ad libitum chopped orchardgrass (Dactylis glomerata)–timothy (Phleum pratense) hay with no
rumen infusions. Images for determining baseline measures were collected when goats were being adapted to the hay diet on the last, fourth, and fifth days prior to
initiating the infusion treatments. Asterisks above the bars denote significant differences between treatment and baseline measures at P < 0.05 (*), P < 0.01 (**), and
P < 0.001 (***) levels of significance. A trend line is provided for Phase B that illustrates the linear relationship between proportionate differences from baseline and
days on treatment.
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FIGURE 3 | Ultrasonic measures in Experiment 2 of proportionate differences from baseline measures for luminal area of the carotid artery in rumenfistulated wether goats that were infused with (A) toxic seed extract only in phase A, and (B) toxic seed extract and isoflavones in phase B. Baseline
measures were taken with goats receiving ad libitum chopped orchardgrass (Dactylis glomerata)–timothy (Phleum pratense) hay with no rumen infusions. Images for
determining baseline measures were collected when goats were being adapted to the hay diet on the last, fourth, and fifth days prior to initiating the infusion
treatments. Asterisks above the bars denote significant differences between treatment and baseline measures at P < 0.05 (*), P < 0.01 (**), and P < 0.001 (***) levels
of significance. A trend line is provided for Phase B that illustrates the linear relationship between proportionate differences from baseline and days on treatment.

FIGURE 4 | Ultrasonic measures in Experiment 2 of proportionate differences from baseline measures for blood flow rate through the carotid artery
in rumen-fistulated wether goats that were infused with (A) toxic seed extract only in phase A, and (B) toxic seed extract and isoflavones in phase B.
Baseline measures were taken with goats receiving ad libitum chopped orchardgrass (Dactylis glomerata)–timothy (Phleum pratense) hay with no rumen infusions.
Images for determining baseline measures were collected when goats were being adapted to the hay diet on the last, fourth, and fifth days prior to initiating the
infusion treatments. Asterisks above the bars denote significant differences between treatment and baseline measures at P < 0.05 (*), P < 0.01 (**), and P < 0.001
(***) levels of significance. A trend line is provided for Phase B that illustrates the linear relationship between proportionate differences from baseline and days on
treatment.

similar (P = 0.338) between baseline measures and both infusion
treatments (Table 1). Heart rate also did not differ (P = 0.339)
between the baseline and infusion treatments. Pulsatility index
with the seed extract infusion was greater (P = 0.025) than the
baseline measure, but decreased back to indices that were similar

baseline measures. By 4 DOT after isoflavones were included with
the seed extract in the infusion, the luminal areas had increased
and stabilized to areas that were similar to baseline measures.
Peak systolic and mean velocities in the carotid artery did not
vary (P = 0.889) over DOT for the infusion treatments, and were
Frontiers in Veterinary Science | www.frontiersin.org
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FIGURE 5 | Ultrasonic measures in Experiment 2 of proportionate differences from baseline measures for luminal area of the interosseous artery in
rumen-fistulated wether goats that were infused with (A) toxic seed extract only in phase A, and (B) toxic seed extract and isoflavones in phase B.
Baseline measures were taken with goats receiving ad libitum chopped orchardgrass (Dactylis glomerata)–timothy (Phleum pratense) hay with no rumen infusions.
Images for determining baseline measures were collected when goats were being adapted to the hay diet on the last, fourth, and fifth days prior to initiating the
infusion treatments. Asterisks above the bars denote significant differences between treatment and baseline measures at P < 0.05 (*), P < 0.01 (**), and P < 0.001
(***) levels of significance.

(P = 0.25) to the baseline average when isoflavones were included
with seed extract in the infusion.

be such that typical diet concentrations of isoflavones are much
lower or higher than what is used in the present experiment.
Dose–response experiments and grazing experiments with
clover–grass mixtures will be needed to determine optimum diet
concentrations of isoflavones for mediation of a response.

DISCUSSION
The focus of this research was to investigate if isoflavones can
mitigate the adverse effects of ergot alkaloids on the hemodynamics of goats. Persistent constriction of blood flow to peripheral
tissues incapacitates the animal’s ability to thermoregulate their
core body temperature. This causes animals being vulnerable to
severe heat stress under moderate ambient temperatures. Recent
research has reported ergot alkaloid-induced vasoconstriction of
the ruminal artery and vein (27), and mesenteric vasculature (28)
in cattle. These results provided strong evidence that exposure
to ergot alkaloids can have a negative influence on nutrient
efficiency.
Low prolactin concentrations are often used as an indicator
that animals are suffering from fescue toxicosis. It would have
been informative to monitor serum prolactin concentrations
in the present experiment with goats; however, it was critical
to control goat temperament and nervousness for accurate
measurement artery lumen areas and blood flow characteristics.
Although body temperature measures and collection of blood
for assaying prolactin concentrations would have been informative, they would likely have caused extraneous error in the ultrasound measures that were necessary in meeting experimental
objectives.
The diet concentrations of isoflavones used in the experiments
were based on the concentration needed to decrease ammonia
production in vitro (24). However, it should be mentioned that
selectivity of clovers relative to grasses and other forages could
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Experiment 1

Ergovaline is the ergopeptine that is consistently in the highest
concentration in toxic endophyte-infected tall fescue (29) and also
has demonstrated to be the most potent ergopeptine produced by
the tall fescue endophyte in mediating a vasoconstrictive response
in bovines (30, 31). Aiken et al. (32) reported a vasoconstrictive
response of the caudal arteries of endophyte-naïve heifers in less
than 48 h after initial consumption of diets containing ground
tall seed in quantities that provided ergovaline concentrations of
0.8 μg/g DM.
Carotid and auricular arteries in goats were reported by
Aiken and Flythe (11) to exhibit a vasoconstrictive response
in 2 days after initial consumption of a diet containing 0.8 μg
ergovaline + ergovalinine/g DM. Responses in Experiment 1
were similar between the carotid and interosseous arteries. A diet
concentration similar to that used by Aiken and Flythe (11) was
fed in the preset experiment, but alkaloid-induced vasoconstriction did not occur over the first 4 days when rumens were infused
with both toxic seed and isoflavones. There did, however, appear
to be vasodilation of the carotid artery at 3 and 4 DOT. The strong
linear decline in luminal areas after isoflavones were removed
from the infusion provided evidence that isoflavones mediated
vaso-relaxation of the carotid artery. Similar to the findings of
Aiken and Flythe (11), significant vasoconstriction occurred at 2
DOT when only the toxic seed was infused.
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Higher pulsatility reflects greater resistance to blood flow;
thus, greater blood flow resistance was observed on 4 DOT
with infusions lacking isoflavones. Greater peak systolic velocity
could also be expected with higher pulsatilities, but there can be
considerable error in these measures due to between-animal and
between-image variations. Aiken and Strickland (33) warned that
placement of the sample gate within the vessel and animal tension
could be major sources of variation between images.

Jia et al. (34) examined the interaction of the isoflavones,
formononetin and biochanin A, and tall fescue seed extract
on the vasoactivity of bovine mesenteric arteries and veins. In
these experiments, the two isoflavones tested did not mitigate
vasoconstriction, which superficially appears to contradict the
results presented here. However, comparison of the studies is
informative. The most obvious difference is that the experiment
performed by Jia and co-workers was in vitro, on a myograph,
and with different blood vessels than those monitored in the
current study. It is well established that β-adrenergic receptors
are differentially expressed in tissue types across species (35, 36).
Thus, isoflavones could have greater impact on some regions of
the vascular system than others, which is consistent with the
activity of known β-adrenergic agonists, such as ractopamine
(37). Second, the mesenteric arteries and veins were exposed
to the isoflavones for 2 h prior to the myograph measurements,
while the goats received the isoflavones in the rumen daily.
Microorganisms metabolize some isoflavones in the rumen (38).
For example, formononetin is converted into daidzein and then
equol, which undergoes renal clearance (39, 40). The detection of
equol in the urine indicates that equol, rather than formononetin,
was present in the blood.
When the results of the current study and the results of Jia and
co-workers are considered together several plausible hypotheses
emerge, including (1) clover isoflavones mitigate vasoconstriction
in the carotid and interosseous arteries, but not in the mesenteric
artery and vein; (2) exposure periods longer than 2 h are required;
and (3) the biologically active forms are microbial metabolites of
the clover isoflavones. Differences in animal species should also
be considered, but previously demonstrated activities in a variety
of animals (including humans and rodents) make differences
between the two ruminant species the less likely possibility (16,
19, 12). It is also possible that the amounts of isoflavones in the
fed tablets were underestimated. The amounts determined in this
study were about 25% of the total isoflavone content reported on
the product label. The discrepancy may reflect differences in the
extraction or the quantitation methods used. It may also be due to
the isoflavone extraction employing 30 min of sonication at ambient temperature instead of refluxing (15 min) at 85°C, the method
used by Krenn et al. (41). Sonication for 30 min in acidified
methanol has thoroughly extracted phenolic compounds from
fruits and vegetables in other studies (42). However, it is possible
that the sonication did not completely extract isoflavones from
the clover tissue. In that case, the amount of isoflavones available to the animal may have exceeded the amounts determined
by the tablet analysis, although it is difficult to determine how
the amounts extracted by acidified methanol would compare to
the amounts extracted by rumen microorganisms in an aqueous
environment.

Experiment 2

Based on reduced luminal areas of both arteries at 6, 7, and 8
DOT during phase A when only the seed extract was infused, the
arteries appeared to have been saturated with ergot alkaloids. This
is because the luminal areas at each of these latter DOT were less
than the baselines and with no declining trends. Furthermore,
blood flow rates in the carotid were similar to the responses
for the luminal areas to seed extract over DOT. Luminal area
and blood flow rate for the carotid were less than baselines on
4 DOT, but linear increases over the latter DOT indicated that
the areas and blood flows were back to baseline levels by 5 DOT
with inclusion of isoflavones in the infusion. Luminal areas of
the interosseous artery did not exhibit increases relative to the
baseline, but were similar to baseline at each of the three DOT;
therefore, vaso-relaxation had occurred prior to 4 DOT.
The responses of the carotid arteries to isoflavones appeared to
be gradual during the phase; however, measures were needed at
earlier DOT to verify that trend. Again, saturation of the carotid
was indicated to have occurred in Phase A, which could have
been a factor in early mitigation of the vasoconstriction. The mitigation of vasoconstriction of the interosseous artery might have
occurred earlier than 4 DOT, which suggests that there could be a
greater density of β-adrenergic receptors in the interosseous than
carotid artery.
It is curious that baseline measures of mean luminal area of
the interosseous were almost fourfold greater in Experiment 1
than in Experiment 2. This was likely related more to the methods
of measuring luminal area and not to differences in accuracy
between the two ultrasound instruments, which was checked.
Aiken et al. (8) concluded that tracing connective tissue in the
intima with a B-mode image could overestimate luminal area and
tracing the color Doppler signal could underestimate the signal.
However, it was difficult without using the color Doppler signal as
a guide to take the measures at the true peak systolic phase of the
cardiac cycle because of a weaker pulse of the interosseous artery,
as compared to the carotid artery. Tracing the color Doppler signal offers more accuracy in taking measures at the peak velocity
during a cardiac cycle, whereas relying on weaker pulses without
color Doppler could cause errors in detection of peak systolic
velocity that would lead to underestimation of luminal area.
Peak systolic velocity and heart rate were not affected by either
infusion treatment; however, the least square mean for pulsatility
index was greater for the seed extract without than with isoflavones, and the baseline measure. Similar mean pulsability indices
between the baseline and the seed extract and isoflavone infusion
further indicated that isoflavones mitigated resistance to blood
flow mediated by the alkaloid-induced vasoconstriction.
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CONCLUSION
Results indicated that isoflavones in the diet of goats grazing
toxic endophyte-infected tall fescue can counter and relieve
ergot alkaloid-induced vasoconstriction. Although results from
Experiment 2 indicated that relief with isoflavones can occur
after goats are exposed to ergot alkaloids, it is uncertain if the
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vasculature of the goats was saturated with ergot alkaloids, which
could have had a bearing on efficacy of the treatment. More
experiments are needed to verify the responses and evaluate
dose–responses for determining threshold concentrations of
isoflavones in the diet for mediating a positive response by the
vasculature. Furthermore, the rapidness of the responses to both
ergot alkaloids and isoflavones were such that valid interpretations and conclusions could be made using Latin square types of
experimental designs, which will be necessary if environmental
controls are not possible. Nonetheless, these results provide strong
evidence that isoflavones produced by legumes can ameliorate the
adverse effects of fescue toxicosis.
Studies with cattle, sheep, and horses should be conducted
to determine if alkaloid-induced vasoconstriction can be
relaxed with exposure to isoflavones. Given that isoflavones
ameliorate alkaloid-induced vasoconstriction in grazing
livestock, management approaches can be developed to utilize
isoflavone containing clovers and other legumes in pastures
or feed additives to alleviate or mitigate severe heat stress
suffered by animals grazing toxic tall fescue in moderate air
temperatures. Relaxation of alkaloid-induced vasoconstriction
from consumption of isoflavones could alleviate or mitigate the
adverse effects of ergot alkaloids on blood circulation and the

ability to thermos-regulate core body temperature. This could
ultimately enhance dry matter intake and improve overall animal performance and well-being. However, findings from the
present experiments should be verified with replicated grazing
trials that use a higher number of animals and with longer term
exposure to ergot alkaloids.
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